Skip to main content

Table 1 Baseline demographic, laboratory and clinimetric data of the cohort (214 patients).

From: Frailty as a novel predictor of achieving comprehensive disease control (CDC) in rheumatoid arthritis

  Mean Median SD 25–75 P
Age (years) 60.25 60.00 12.72 50.00–70.00
Disease duration (years) 7.34 7.00 2.59 5.00–10.00
Educational level (years) 11.17 13.00 4.20 8.00–13.00
BMI (kg/m2) 26.39 4.48 25.52 23.03–28.71
RDCI (score, 0–11) 1.90 1.00 2.01 0.00–3.00
ACPA (titre, UI/ml) 232.46 120.00 383.31 10.00–309.00
RF (titre, UI/ml) 141.92 55.60 209.95 10.00–151.00
HAQ-DI (score, 0–3) 0.92 0.92 0.42 0.62–1.12
SDAI (score, 0–86) 27.09 25.24 12.49 20.32–36.25
SENS (score, 0–78) 11.71 12.00 7.19 5.00–17.00
CRAF (score, 0–10) 0.25 0.20 0.20 0.08–0.43
  1. SD standard deviation, P percentiles, BMI body mass index, RDCI Rheumatic Diseases Comorbidity Index, HAQ-DI Health Assessment Questionnaires Disability Index, ACPA anti-cyclic citrullinated peptide antibodies, RF rheumatoid factor, SDAI Simplified Disease Activity Index, SENS Simple Erosion Narrowing Score, CRAF Comprehensive Rheumatologic Assessment of Frailty